TSX/CURA (TSX/CURA)

Toronto Stock Exchange: TSX/CURA · CAD

CA$11.8

-0.12 (-1.0%)· Recorded snapshot

Market cap	3.1B
Revenue (ttm)	1.9B
Net income (ttm)	-73.9M
EPS (ttm)	-CA$0.29
Shares out	265M
Volume	88,121
Beta	1.60

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 1.9B
Net income (ttm): -73.9M
EPS (ttm): -CA$0.29
Market cap: 3.1B

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-28 19:55 UTC

Forward P/En/a

P25 11.1P50 16.7P75 23.4

Trailing P/En/a

P25 9.7P50 23.2P75 38.2

ROE-2.4

P25 -102.4P50 -28.4P75 6.8

ROIC0.8

P25 -55.9P50 -11.8P75 5.8

Benchmarks · 1M

All TSX/CURA indicators

Market & fundamental data

Available fields

217

Groups with data

Currency

USD

Showing 217 of 217 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	CAD
Country	Canada
Country code	CA
Earnings date	2026-11-03
Employees	5,554
Employees change	35
Employees growth	0.63%
Enterprise value	CAD 4.6B
Exchange	Toronto Stock Exchange
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-05-10
Fiscal year end	December
Founded	2010
Industry	Drug Manufacturers - Specialty & Generic
Is primary listing	Yes
ISIN number	CA23126M3003
Last earnings date	2026-05-05
Last refreshed	2026-10-28
Last stock split date	2026-06-05
Last stock split type	Reverse
Market cap	CAD 3.1B
Next earnings date	2026-11-03
Price	CAD 11.83
Price currency	CAD
Sector	Healthcare
SIC code	2834
Stock price date	2026-10-28
Symbol	tsx/CURA
Website	https://www.curaleaf.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Adjusted P/E ratio	369.51x
Earnings yield	-2.42%
EV/EBIT	219.41x
EV/EBITDA	12.09x
EV/FCF	43.1x
EV/Sales	2.47x
FCF / EV yield	2.32%
FCF yield	3.38%
Industry forward P/E	34.53x
P/(FCF - SBC) ratio	68.3x
P/(OCF - SBC) ratio	22.71x
P/B ratio	2.57x
P/FCF ratio	29.57x
P/OCF ratio	15.82x
P/S ratio	1.7x
Price/EBITDA ratio	10.62x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	1.13%
EBITDA margin	15.96%
FCF margin	5.8%
Gross margin	49.39%
Operating margin	1.13%
Pretax margin	-7.64%
Profit margin	-2.63%
Profit per employee	CAD -13,303
Profitable quarters	2
Revenue per employee	CAD 336,297
ROA	0.32%
ROA (5Y)	0.89%
ROCE	0.59%
ROE	-2.35%
ROE (5Y)	-18.31%
ROIC	0.79%
ROIC (5Y)	2.08%
SBC / revenue	3.25%
Tax / revenue	-6.03%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth (QoQ)	-82.3%
EPS growth quarters	3
EPS growth years	0
FCF growth	44.88%
FCF growth (QoQ)	232.9%
Gross profit growth	3.43%
Gross profit growth (Q)	10.99%
Gross profit growth 3Y	2.94%
Gross profit growth 5Y	4.5%
Net income growth (QoQ)	-81.98%
Net income growth quarters	3
Net income growth years	0
OCF growth	2.51%
OCF growth (Q)	242.26%
OCF growth (QoQ)	39.39%
OCF growth 3Y	25.79%
Operating income growth	-26.33%
Operating income growth (Q)	-32.4%
Operating income growth 3Y	1.61%
Operating income growth 5Y	-30.88%
Revenue growth	3.54%
Revenue growth (Q)	9.5%
Revenue growth (QoQ)	4.89%
Revenue growth 3Y	-0.48%
Revenue growth 5Y	5.97%
Revenue growth quarters	3
Revenue growth years	0

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	CAD -93.1M
Depreciation and amortization	CAD 273.9M
EBIT	CAD 21M
EBITDA	CAD 298.1M
EPS	CAD -0.29
FCF per share	CAD 0.40
Financing cash flow	CAD -92.8M
Free cash flow	CAD 107.1M
Free cash flow minus SBC	CAD 46.4M
Gross profit	CAD 922.5M
Income taxes	CAD -112.6M
Investing cash flow	CAD -99.9M
Net borrowing	CAD 40.3M
Net cash flow	CAD 6.7M
Net income	CAD -73.9M
Operating cash flow minus SBC	CAD 139.5M
Operating income	CAD 21M
Revenue	CAD 1.9B
Stock-based compensation	CAD 60.7M

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	0.44
Book value per share	CAD 4.65
Debt / EBITDA	4.15
Debt / equity	1.29
Debt / FCF	14.78
Goodwill	CAD 888.7M
Interest coverage	0.14
Long-term assets	CAD 3.3B
Long-term liabilities	CAD 2.3B
Net cash (debt)	CAD -1.4B
Net cash / market cap	-45.75%
Net debt / EBITDA	4.86
Net debt / equity	1.18
Net debt / FCF	13.53
Piotroski F-Score	5
Property, plant and equipment	CAD 1B
Shareholders' equity	CAD 1.2B
Tangible book value	CAD -1B
Tangible book value per share	CAD -3.87
Total assets	CAD 4B
Total cash	CAD 134.3M
Total debt	CAD 1.6B
Total liabilities	CAD 2.8B
WACC	11.12%

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0.46
Current assets	CAD 656.7M
Current liabilities	CAD 431.1M
Current ratio	1.52
Inventory turnover	2.83
Net working capital	CAD 217M
Quick ratio	0.55
Working capital	CAD 228.2M
Working capital turnover	12.54

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	-3.46%
Shareholder yield	-3.46%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
150-day SMA	CAD 13.28
1D price change	-1%
1M price change	-25.05%
1M total return	-25.05%
1W price change	5.96%
1W total return	5.96%
1Y price change	-2.49%
1Y return CAGR	-2.5%
1Y total return	-2.49%
20-day SMA	CAD 12.54
200-day SMA	CAD 12.41
3M price change	-7.13%
3M total return	-7.13%
3Y price change	2.63%
3Y return CAGR	0.87%
3Y total return	2.63%
50-day SMA	CAD 13.49
50-day SMA vs 200-day SMA	50over200
52-week high	CAD 20.93
52-week high date	2025-12-18
52-week low	CAD 7.77
52-week low date	2026-03-30
5Y price change	-68.31%
5Y return CAGR	-20.54%
5Y total return	-68.31%
6M price change	-16.63%
6M total return	-16.63%
All-time high	CAD 69.90
All-time high date	2021-02-10
All-time low	CAD 2.97
All-time low date	2025-06-24
Average true range (ATR)	CAD 0.67
Average volume	320.5K
Beta (1Y)	1.12
Beta (2Y)	1.93
Beta (5Y)	1.6
Change from 52-week high	-43.46%
Change from 52-week low	52.25%
Change from all-time high	-83.22%
Change from all-time low	294.95%
Change from open	-1.66%
Day's gap	0.67%
Dollar volume	CAD 1M
High price	CAD 12.04
Low price	CAD 11.67
Monthly RSI	49.03
Open price	CAD 12.03
Position in 52-week range	43.24%
Previous close	CAD 11.95
Price vs 150-day SMA	-11.67%
Price vs 20-day SMA	-6.44%
Price vs 200-day SMA	-5.5%
Price vs 50-day SMA	-13.07%
Relative volume	0.27
RSI	40.47
Sharpe ratio	0.43
Sharpe ratio (3Y)	0.37
Sharpe ratio (5Y)	0.11
Sortino ratio	0.72
Sortino ratio (3Y)	0.66
Sortino ratio (5Y)	0.24
Volume	88.1K
Weekly RSI	44.8
YTD price change	14.66%
YTD total return	14.66%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	214.8M
Shares change (QoQ)	2.58%
Shares change (YoY)	3.46%
Shares held by insiders	6.38%
Shares held by institutions	10.36%
Shares outstanding	265M

Deeper analysis on TSX/CURA

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this TSX/CURA report

Is a complete TSX/CURA research report available?

No complete published report is available for tsx/CURA (TSX/CURA) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

TSX/CURA (TSX/CURA)

Price

Financial snapshot

Fair-value bridge

Latest news · TSX/CURA

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All TSX/CURA indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on TSX/CURA

Frequently asked questions